Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
I-kappa B Kinase | 2 | 2019 | 250 | 1.050 |
Why?
|
Carcinoma, Ductal, Breast | 4 | 2020 | 1085 | 0.900 |
Why?
|
Carcinoma, Lobular | 3 | 2019 | 481 | 0.590 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 250 | 0.590 |
Why?
|
Chemokine CCL5 | 2 | 2014 | 214 | 0.480 |
Why?
|
Breast Neoplasms | 9 | 2022 | 21017 | 0.460 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2020 | 926 | 0.430 |
Why?
|
Premenopause | 1 | 2015 | 1039 | 0.360 |
Why?
|
Immunity, Innate | 2 | 2019 | 3066 | 0.350 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2015 | 1520 | 0.270 |
Why?
|
Axilla | 4 | 2022 | 624 | 0.260 |
Why?
|
Interleukin-6 | 2 | 2014 | 3208 | 0.250 |
Why?
|
Phosphoproteins | 2 | 2024 | 2448 | 0.240 |
Why?
|
Sentinel Lymph Node Biopsy | 4 | 2022 | 732 | 0.220 |
Why?
|
Testicular Hormones | 1 | 2003 | 188 | 0.220 |
Why?
|
Exodeoxyribonucleases | 1 | 2024 | 192 | 0.210 |
Why?
|
Signal Transduction | 5 | 2024 | 23447 | 0.210 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3617 | 0.200 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2003 | 305 | 0.200 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11742 | 0.190 |
Why?
|
Lymph Nodes | 3 | 2022 | 3466 | 0.190 |
Why?
|
Interferons | 2 | 2024 | 706 | 0.160 |
Why?
|
Benzamides | 2 | 2014 | 1370 | 0.150 |
Why?
|
Neoadjuvant Therapy | 3 | 2022 | 2827 | 0.150 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2019 | 1693 | 0.130 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2557 | 0.130 |
Why?
|
Cell Division | 1 | 2003 | 4465 | 0.130 |
Why?
|
Glycoproteins | 1 | 2003 | 2203 | 0.130 |
Why?
|
Serine | 1 | 2019 | 830 | 0.130 |
Why?
|
Membrane Proteins | 2 | 2024 | 7858 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1745 | 0.120 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2022 | 3514 | 0.120 |
Why?
|
Neoplasm, Residual | 1 | 2019 | 1008 | 0.110 |
Why?
|
PTEN Phosphohydrolase | 1 | 2019 | 1115 | 0.110 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 16986 | 0.110 |
Why?
|
Janus Kinases | 1 | 2014 | 248 | 0.110 |
Why?
|
Autocrine Communication | 1 | 2014 | 169 | 0.110 |
Why?
|
Pyrimidines | 2 | 2014 | 3028 | 0.100 |
Why?
|
Neoplasm Staging | 3 | 2022 | 11121 | 0.100 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.090 |
Why?
|
Lymph Node Excision | 3 | 2022 | 1271 | 0.090 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3603 | 0.090 |
Why?
|
Breast | 1 | 2019 | 1967 | 0.090 |
Why?
|
Tamoxifen | 1 | 2015 | 965 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2019 | 4280 | 0.090 |
Why?
|
Mastectomy | 1 | 2018 | 1822 | 0.080 |
Why?
|
Nitriles | 1 | 2015 | 971 | 0.080 |
Why?
|
Triazoles | 1 | 2015 | 903 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2015 | 1148 | 0.080 |
Why?
|
Nuclear Proteins | 1 | 2003 | 5799 | 0.080 |
Why?
|
Proteins | 1 | 2003 | 6032 | 0.080 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6132 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2020 | 5315 | 0.080 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.080 |
Why?
|
Phosphorylation | 1 | 2019 | 8321 | 0.080 |
Why?
|
Thyroid Neoplasms | 1 | 2022 | 2332 | 0.080 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4915 | 0.070 |
Why?
|
Spheroids, Cellular | 2 | 2020 | 330 | 0.070 |
Why?
|
Cell Adhesion Molecules | 1 | 2013 | 1601 | 0.070 |
Why?
|
Receptors, Estrogen | 1 | 2015 | 2208 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13382 | 0.070 |
Why?
|
NF-kappa B | 1 | 2014 | 2490 | 0.060 |
Why?
|
Mutation | 2 | 2020 | 30054 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1993 | 0.060 |
Why?
|
Humans | 17 | 2024 | 761572 | 0.060 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2003 | 73 | 0.060 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2003 | 71 | 0.060 |
Why?
|
Mullerian Ducts | 1 | 2003 | 203 | 0.050 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 866 | 0.050 |
Why?
|
COS Cells | 1 | 2003 | 1130 | 0.050 |
Why?
|
Female | 10 | 2022 | 392686 | 0.050 |
Why?
|
Anti-Mullerian Hormone | 1 | 2003 | 407 | 0.050 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2915 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2019 | 3597 | 0.040 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2003 | 655 | 0.040 |
Why?
|
Retinoblastoma Protein | 1 | 2003 | 672 | 0.040 |
Why?
|
Mice | 5 | 2024 | 81533 | 0.040 |
Why?
|
Cervix Uteri | 1 | 2003 | 570 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9280 | 0.040 |
Why?
|
Genes, ras | 1 | 2022 | 654 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2022 | 383 | 0.040 |
Why?
|
Animals | 7 | 2024 | 168467 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2022 | 1031 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8528 | 0.030 |
Why?
|
Time-Lapse Imaging | 1 | 2017 | 194 | 0.030 |
Why?
|
Blotting, Western | 1 | 2003 | 5035 | 0.030 |
Why?
|
Prospective Studies | 4 | 2022 | 54426 | 0.030 |
Why?
|
Transfection | 1 | 2003 | 5774 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1827 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3272 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2201 | 0.030 |
Why?
|
Mice, SCID | 1 | 2020 | 2626 | 0.030 |
Why?
|
Quinolines | 1 | 2020 | 764 | 0.030 |
Why?
|
Neoplasms | 2 | 2024 | 22173 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 2014 | 211 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1869 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2003 | 3449 | 0.020 |
Why?
|
Mice, Nude | 1 | 2018 | 3614 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11076 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2020 | 80646 | 0.020 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2003 | 2020 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 550 | 0.020 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2017 | 803 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1667 | 0.020 |
Why?
|
Cell Line | 1 | 2003 | 15601 | 0.020 |
Why?
|
Middle Aged | 4 | 2019 | 220920 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1229 | 0.020 |
Why?
|
Adult | 3 | 2019 | 221203 | 0.020 |
Why?
|
Rats | 1 | 2003 | 23741 | 0.020 |
Why?
|
Disease Management | 1 | 2018 | 2508 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39107 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2017 | 5869 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29629 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12725 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10448 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9489 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58986 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7396 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5305 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8552 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5672 | 0.010 |
Why?
|
Aged | 2 | 2019 | 169310 | 0.010 |
Why?
|
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_